Candida albicans can enter skeletal tissue through a skin wound in an immunocompromised host or by contamination during orthopedic surgery. Such Candida osteomyelitis is accompanied by severe pain and bone destruction. It is established that nociceptor innervation occurs in skin and bone, but the mechanisms of nociceptive modulation in fungal inflammation remain unclear. In this study, we show that C. albicans stimulates Nav1.8-positive nociceptors via the b-glucan receptor Dectin-1 to induce calcitonin gene-related peptide (CGRP). This induction of CGRP is independent of Bcl-10 or Malt-1 but dependent on transient receptor potential cation channel subfamily V member 1 (TRPV1)/transient receptor potential cation channel subfamily A member 1 (TRPA1) ion channels. Hindpaw b-glucan injection after Nav1.8-positive nociceptor ablation or in TRPV1/TRPA1 deficiency showed dramatically increased osteoinflammation accompanied by impaired CGRP production. Strikingly, CGRP suppressed b-glucan-induced inflammation and osteoclast multinucleation via direct suppression of nuclear factor-kB (NF-kB) p65 by the transcriptional repressor Jdp2 and inhibition of actin polymerization, respectively. These findings clearly suggest a role for Dectin-1-mediated sensocrine pathways in the resolution of fungal osteoinflammation.
INTRODUCTION
The number of immunosuppressed patients, which includes individuals undergoing organ transplantation, anti-cancer drug treatment, or immunosuppressive therapy or those with HIV/AIDS, has increased significantly in recent years. As a result of advances of emergency medicine, most immunosuppressive complications no longer pose a threat to patients. However, this has caused an increase in various opportunistic infections. Notably, Candida albicans infection is one of the major fungal infections observed in immunosuppressed patients (Kullberg and Arendrup, 2015; Pfaller and Diekema, 2004; Yapar, 2014) .
Osteomyelitis, an infection characterized by severe inflammation and bone destruction, is difficult to treat. It is well recognized that C. albicans can also enter skeletal tissue through a skin wound or by contamination during orthopedic surgery (Arias et al., 2004; Miller and Mejicano, 2001; Rodríguez et al., 2003) . Although invasive fungal infections are increasing in immunodeficient hosts, osteomyelitis caused by fungi is a relatively rare infection. However, C. albicans osteomyelitis is associated with significant morbidity, and a recent study suggested that it has been reported with increasing frequency from 1970 to 2011 (Gamaletsou et al., 2012) . Thus, understanding the pathogenesis of C. albicans osteomyelitis is an important issue in the field of orthopedics and osteoimmunology.
It is well established that nociceptor innervation occurs in skin and bone. The function of nociceptors in the osteo-immune system is unclear, but ion channels expressed in the dorsal root ganglia (DRG) are thought to be responsible for sensing noxious stimuli (Woolf and Costigan, 1999) . Nav1.8 is a TTX-resistant voltage-gated sodium channel expressed in DRG that is involved in nociception (Zimmermann et al., 2007) . Transient receptor potential (TRP) channels are also key players in nociception; in particular, TRP cation channel subfamily V member 1 (TRPV1) and TRP cation channel subfamily A member 1TRPA1 are critical channels that mediate nociceptive signaling (Julius, 2013) . Recently, it has been reported that nociceptors modulate gram-negative bacterial infections via neuropeptides (Chiu et al., 2013) . Capsaicin injection into animals leads to osteoporosis (Ding et al., 2010) . Thus, nociceptors may modulate the osteo-immune system, but the mechanism by which they modulate fungal osteomyelitis remains largely unknown.
Fungal cell walls are composed of b-glucan on the inner surface and mannan on the outer surface (Gow et al., 2011) . Innate immune cells recognize fungal mannan mainly through Toll-like receptors (TLRs), leading to the production of cytokines via MyD88 and TRIF (Underhill and Iliev, 2014) . Mannan is also recognized by the mannose receptor, Dectin-2, DC-SIGN, and Mincle on innate immune cells (Lionakis and Netea, 2013) . During budding growth, b-glucan is exposed to the fungal surface or secreted and is sensed by Dectin-1 (Saijo et al., 2007) . Dectin-1 induces signaling via the ITAM-like motif, leading to the CARD-9/Bcl-10/Malt-1 trimer and inducing nuclear factor-kB (NF-kB) activation (Underhill and Iliev, 2014) .
In this study, we discovered that selective depletion of Nav1.8-positive nociceptors leads to exaggerated C.-albicansinduced inflammation and bone destruction. C.-albicans-derived b-glucan activates Nav1.8-positive nociceptors via the Dectin-1-TRPV1/TRPA1 axis, leading to the production of calcitonin gene-related peptide (CGRP). Notably, CGRP inhibited b-glucan-induced cytokine production and bone resorbing osteoclasts via inhibition of NF-kB p65 by the transcriptional repressor Jdp2 and inhibition of actin polymerization, respectively.
RESULTS

Osteoporotic Phenotype of Pain-Nerve-Ablated Mice
To evaluate the function of nociceptor-mediated bone homeostasis, we analyzed the osteo-immune system of resiniferatoxin (RTX)-treated mice (TRPV1-positive neuron ablation; Figures  1A-1C ) and Nav1.8CreRosa26DTA mice. Both types of mice had normal myeloid and lymphoid populations in splenocytes, but bone volume per tissue volume in distal femurs was significantly impaired ( Figures 1D-1F and 1J-1L). Osteoclast parameters were increased in both types of mice, indicating that the absence of nociceptors negatively affects osteoclast generation in vivo . Collectively, these findings suggest that nociceptors have the ability to protect bone. Nav1.8-Positive Pain Nerve Ablation Increases Fungal Osteoinflammation To visualize Nav1.8-positive nociceptors, we generated Nav1.8Cre Rosa 26 tdRFP mice. Fluorescence microscope analysis revealed that Nav1.8-positive nociceptors are innervated into calcaneus ( Figure S1A ). Intriguingly, Dectin-1, a C. albicans and b-glucan receptor, was expressed in nociceptors such as DRG and trigeminal ganglion ( Figure S1B ). To evaluate the function of nociceptor-mediated fungal osteoinflammation, we next injected C. albicans or C.-albicans-derived soluble b-glucan (CSBG) (Ishibashi et al., 2002) into RTX-treated mice and Nav1.8CreRosa26DTA mice. After C. albicans or CSBG injection into the hindpaw, both mice showed dramatically increased footpad swelling, serum tumor necrosis factor alpha (TNF-a) levels, calcaneus surface erosion, and serum bone destruction marker levels compared with control mice (Figures  2A-2C ). Histological analysis of the calcaneus from CSBGinjected Nav1.8CreRosa26DTA mice revealed a dramatic increase in osteoclast numbers ( Figures 2D and 2E ). Interleukin-23 (IL-23) and IL-17 cytokine expression and fungal burden were normal in C.-albicans-or CSBG-injected hindpaws of Nav1.8CreRosa26DTA mice ( Figures S1C and S1D ). When we intravenously injected neutralizing TNF-a antibody into CSBGtreated wild-type mice, hindpaw swelling and calcaneus bone destruction were significantly impaired compared with control immunoglobulin G (IgG)-injected wild-type mice ( Figures 3A-3C ). Depletion of T cells using anti-CD3 antibody did not affect CSBG-induced hindpaw inflammation or bone destruction (Figures S2A and S2B) . In contrast to CSBG injection, Nav1.8CreRosa26DTA mice that received a lipopolysaccharide (LPS) injection into the hindpaw showed a mild increase in footpad swelling compared with control mice (Figures 3D-3F ). Differences in hindpaw TNF-a and IL-6 expression between wild-type and Nav1.8CreRosa26DTA mice were more significant in response to CSBG injection than LPS injection ( Figure 3G ). Despite normal cytokine production by neutrophils in response to various fungal or bacterial components ( Figure 3H ), Nav1.8CreRosa26DTA mice are highly susceptible to the intraperitoneal injection of the Dectin-1 ligand Curdlan, but not to LPS ( Figures 3I-3L) . Thus, Dectin-1-mediated osteoinflammation, but not TLR4-mediated osteoinflammation, is potently suppressed by nociceptors.
b-Glucan Induces Robust CGRP Secretion from Sensory Nerves through the Dectin1-PLC-TRPV1/TRPA1 Axis Pain nerves express neuropeptides such as neurokinin A, substance P, galanin, somatostatin, and CGRP. CGRP is the only one of these peptides that is secreted into the serum or synovial tissue after C. albicans injection into the hindpaw (Figures 4A and 4B) . Because CGRP inhibits TLR4 signaling (Nong et al., 1989) and is present at high levels in DRG neurons but barely detectable in other tissues or cells ( Figure 4C ), we hypothesized that Dectin-1-stimulated DRG neurons inhibit osteo-inflammation via CGRP production. In vitro analysis revealed that CGRP is released from DRG neurons in response to CSBG or heat-killed (hk) C. albicans, and this secretion was dependent on extracellular Ca 2+ , phospholipase C (PLC), and Dectin-1 ( Figure 4D ). TRPV1 or TRPA1 single-deficient DRG neurons showed partial, and TRPV1/TRPA1 double-deficient DRG neurons showed severe, impairment of CGRP production in response to CSBG or hk C. albicans stimulation ( Figure 4D ). Constitutive serum CGRP levels were lower in Nav1.8CreRosa26DTA mice than in control mice ( Figure 4E ). After hindpaw injection of hk C. albicans or CSBG, serum CGRP induction was significantly impaired in RTX-treated mice and Nav1.8CreRosa26DTA mice compared with control mice ( Figure 4E ). Dectin-1-deficient or PLC-inhibitor-treated mice also showed severely impaired serum CGRP induction in response to hindpaw CSBG injection ( Figure 4F ). By contrast, Bcl-10-or Malt-1-deficient mice showed normal serum CGRP production in response to CSBG ( Figure 4F ). TRPV1 or TRPA1 single-deficient mice showed partial, and TRPV1/TRPA1 double-deficient mice showed significant, impairment of serum CGRP levels in response to hindpaw injection of CSBG or hk C. albicans ( Figure 4F ). CGRP co-administration into the hindpaw reversed the hyperinflammatory and bonedestructive phenotype in Nav1.8CreRosa26DTA mice in response to CSBG (Figures S2A and S2B) . Reflecting the weak inhibitory effect of LPS-induced inflammation in pain nerves, an increase in 
-Positive Nociceptors
(A-C) To neutralize TNF-a, an anti-TNF-a antibody or isotype control antibody were intraperitoneally injected. After 12 hr, CSBG (150 mg) was injected into the hindpaws of mice. Representative images of the hindpaws (top), ankle mCT images (middle), and the axial view of calcaneus mCT images (bottom) at day 6 after CSBG injection are presented in (A). Sequential hindpaw thickness is shown in (B). Eroded area/total area of the calcaneus surface (%) and BV/TV of the calcaneus in (A) are indicated in (C) (n = 8).
(D-F) LPS (150 mg) was injected into hindpaws of Nav1.8CreRosa26DTA mice. Representative pictures of hindpaws (top), ankle mCT images (middle), and the axial view of calcaneus mCT images (bottom) at day 6 after LPS injection are presented (D). Sequential hindpaw thickness is shown in (E). Eroded area/total area of the calcaneus surface (%) and BV/TV of the calcaneus in (F) are indicated in (G) (n = 8).
(G) LPS or CSBG was injected into the hindpaws of Nav1.8CreRosa26DTA mice. After 6 days, TNF-a and IL-6 expression levels in the hindpaw tissues were analyzed using qPCR (n = 5).
(H) Neutrophils from Nav1.8CreRosa26DTA mice were collected and stimulated by various fungal and bacterial components. After 24 hr, TNF-a levels in the supernatant were measured (n = 5).
(I and J) Curdlan was intraperitoneally injected into Nav1.8CreRosa26DTA mice, and survival was monitored (I). Serum cytokine levels were determined 18 hr after injection (J; n = 5).
(K and L) LPS was intraperitoneally injected into Nav1.8CreRosa26DTA mice and survival was monitored (K). Serum cytokine levels were determined 18 hr after injection (L; n = 10). Error bars represent SE; *p < 0.05; **p < 0.01; ***p < 0.001.
serum CGRP in response to hindpaw CSBG or Curdlan injection was stronger and more sustained that that produced by LPS injection ( Figures S2C and S2D ). Finally, we tested whether loss of TRPV1 and/or TRPA1 deficiency altered the osteo-immune response to b-glucan. TRPV1 and/or TRPA1 deficiency showed normal bone metabolism and hematopoiesis ( Figures S3A-S3C ). In vitro receptor activator of NF-kB ligand (RANKL) and TNF-a-induced osteoclastogenesis in these mice was also unaltered compared with wild-type controls ( Figures S3D and S3E ). Despite normal cytokine production in myeloid cells in response to various fungal or bacterial components (Figures S3F and S3G) , TRPV1/TRPA1 double-deficient mice showed significantly enhanced hindpaw swelling, serum IL-6 concentration, and calcaneus bone destruction in response to CSBG injection into (C) Relative CGRP expression levels (n = 3).
(D) CGRP levels in the culture supernatant from DRG neurons cultured for 24 hr with or without Ca 2+ -containing medium and U73122 (10 mM) and stimulated by CSBG or heat-killed (hk) C. albicans (n = 3).
(E) Serum CGRP levels in denervated mice (RTX-treated mice or Nav1.8Cre Rosa 26DTA mice) injected with hk C. albicans (3 3 10 7 CFUs/25 mL) or CSBG (150 mg/25 mL) (n = 4/group). (F) Serum CGRP levels in various knockout mice injected with hk C. albicans (3 3 10 7 CFUs/25 mL) or CSBG (150 mg/25 mL) (n = 4/group).
Error bars represent SE; *p < 0.05; **p < 0.01; ***p < 0.001.
the hindpaw (Figures 5A-5C ). TRPV1 or TRPA1 single-knockout mice also showed enhanced osteoinflammation in response to CSBG, and the relative contribution of each TRP channel to the phenotypes observed in double-knockout mice was more significant with TRPV1 ( Figures 5A-5C ). Strikingly, CGRP injection with CSBG reversed the hyper-inflammatory and bone destructive phenotype of TRPV1/TRPA1 double-deficient mice ( Figures 5A-5C ). These findings clearly indicated that Dectin-1-PLC-TRPV1/ TRPA1-axis-induced CGRP secretion from the sensory nerves controls the resolution of fungal osteoinflammation. (C) Serum IL-6 levels, the eroded area/total area of the calcaneus surface (%) in (A), and the bone volume/tissue volume of the calcaneus (%) in (A) (n = 7). Error bars represent SE; *p < 0.05; **p < 0.01; ***p < 0.001.
Pain-Nerve-Derived CGRP Inhibits Osteoclast Multinucleation, but Not Differentiation To test the potential role of neuropeptides in osteoclast formation, we screened pain nerves expressing neuropeptides in RANKL-induced osteoclastogenesis. Compared with the PBS control, only CGRP inhibited osteoclast multinucleation and bone-resorptive activity ( Figures 6A-6F) . In contrast to the severe impairment of osteoclastogenesis, osteoclast marker expression, such as that of Jdp2 (Maruyama et al., 2012a) , remained unchanged ( Figure 6C ), and RANKL-induced Jdp2 induction was not affected by Dectin-1 signaling ( Figure 6G ). We also quantified expression of the various osteoclast-associated genes and apoptosis levels in CGRP-treated osteoclasts, but all remained unchanged ( Figures 6H and 6I) . Neurokinin A caused a slight increase in osteoclast differentiation ( Figures  6A-6C ) that required further analysis. Of all neuropeptides tested, CGRP treatment was the most potent inhibitor of osteoclasts. Importantly, expression of CGRP receptors, such as RAMP1 and CALCRL, was detected in osteoclasts ( Figures  S4A, S4B , and S4D). Combination treatment of macrophages with CGRP and RANKL caused time-dependent cyclic AMP (cAMP) accumulation, which was not seen in RANKL single stimulation ( Figure 6J ), and the RANKL-induced Jdp2 increase was not affected by CGRP or cAMP co-stimulation ( Figure 6K ). Because cAMP has been reported to modulate F-actin polymerization, we compared CGRP and cAMP effects on osteoclast actin belt formation. CGRP started to destroy the osteoclast actin belt at 3 hr, and it was eliminated at 12 hr ( Figure 6L ). The importance of cAMP for the CGRP effect on actin belt de-polymerization suggests that cAMP mimics the effect of CGRP (Figure 6L) . The DRG culture supernatant inhibited osteoclast multinucleation, and treatment with olcegepant, a CGRP receptor antagonist, reversed this effect ( Figure 6M ). Thus, we conclude that pain-nerve-derived CGRP inhibits actin polymerization via cAMP induction, leading to the impairment of osteoclast multinucleation ( Figure 7I ).
Pain-Nerve-Derived CGRP Inhibits b-Glucan-Induced Inflammation via the Transcriptional Repressor Jdp2
We screened neuropeptides to analyze their effects on TNF-a production from hk C.-albicans-stimulated macrophages and revealed that only CGRP had the potential to inhibit TNF-a production ( Figure 7A ). Notably, CGRP receptors, such as RAMP1 and CALCRL, were expressed on myeloid cells, and C. albicans infection upregulated the expression of CALCRL (Figures S4A-S4C ). Because CGRP inhibited CSBG and C.-albicans-derived particulate b-glucan (CPBG)-induced (Ishibashi et al., 2002) TNF-a production more strongly than mannan ( Figure 7B ), we hypothesized that CGRP mainly suppresses Dectin-1 signaling rather than TLR signaling. Because the transcriptional repressor Jdp2 is not induced by LPS but represses the transcriptional activities of various transcription factors (Maruyama et al., 2012a) , we compared Jdp2 induction levels in response to C. albicans components. Mannan, CPBG, or CSBG single stimulation could not induce Jdp2 expression, but addition of CGRP with CPBG or CSBG significantly induced Jdp2 ( Figure 7C ). The addition of cAMP to mannan, CPBG, or CSBG also significantly stimulated Jdp2 induction ( Figure 7C ). CPBG stimulation alone did not induce cAMP induction, but CPBG plus CGRP stimulation induced cAMP induction, indicating that Dectin-1 plus CGRP signaling is required for cAMP-mediated Jdp2 induction (Figure 7D ). Myeloid cells from Jdp2-deficient mice showed normal TNF-a and IL-6 production in response to Dectin-1 stimulation ( Figures 7E and S5A) . However, CGRP-or cAMP-mediated suppression of TNF-a and IL-6 production in response to Dectin-1 stimulation was completely abolished in Jdp2-deficient myeloid cells ( Figure 7E ). Serum CGRP concentrations were significantly elevated, and serum CGRP increases in response to CSBG hindpaw injection were significantly higher, in Jdp2-deficient mice than in wild-type mice ( Figure S5B ). Hindpaw swelling and IL-6 concentrations in serum were also elevated, and RTX denervation or CGRP injection did not influence the CSBG-induced hyper-inflammatory phenotype of Jdp2-deficient mice ( Figures  S5C-S5E ). Chimeric wild-type mice lacking Jdp2 in their hematopoietic system showed enhanced footpad swelling and serum cytokine levels in response to CSBG ( Figures S5F-S5H ). Conversely, chimeric knockout mice possessing wild-type bone marrow showed a normal inflammatory phenotype ( Figures  S5F-S5H ). Thus, enhanced Dectin-1-mediated inflammation in Jdp2-deficient mice may be a result of unresponsiveness to CGRP in the hematopoietic system. To gain insight into the mechanism underlying Jdp2-mediated cytokine suppression, we first examined NF-kB p65 activation in response to CPBG alone or CPBG plus CGRP, revealing that p65 DNA binding to its promoter was not impaired in CPBG-plus-CGRP-treated Jdp2-deficient macrophages ( Figure 7F ). Importantly, an association between Jdp2 and p65 was identified by immunoprecipitation ( Figure 7G ). CPBG-or CSBG-induced p65 binding to the TNF-a promoter was suppressed by CGRP or cAMP treatment and by Jdp2 overexpression ( Figure 7H ). Conversely, RANKLinduced p65 binding to the promoter of NFATc1, a master regulator of osteoclastogenesis, was not altered by Jdp2 overexpression ( Figure 7H ). These findings indicated that CGRP-induced Jdp2 in myeloid cells selectively blocks Dectin-1-mediated pro-inflammatory cytokine production by direct p65 inhibition ( Figure 7I ).
DISCUSSION
In both skin and bone, Nav1.8-positive nociceptors seem to be the primary source of CGRP. CGRP suppressed b-glucaninduced cytokine production from myeloid cells and RANKLinduced osteoclast multinucleation via the induction of the transcriptional repressor Jdp2 and cAMP, respectively ( Figure 7I ). Recent reports suggest that denervated mice showed impaired IL-23/IL-17-mediated skin inflammation in response to C. albicans (Kashem et al., 2015) . However, we did not detect any differences in IL-23/IL-17 levels or fungal burden in Nav1.8CreRosa26DTA mice injected with C. albicans, and they showed severe paw inflammation and bone destruction compared with controls. Discrepancies between our findings and a previous report may be explained by the difference in the denervation method used for nociceptors or fungal strains. To generate denervated mice, the previous report mechanically disrupted the cutaneous nerves on one lateral half of the mouse dorsum (Kashem et al., 2015) . By contrast, we used targeted (F) Scanning electron microscopic quantification of the dentine slice surface eroded by osteoclasts cultured with or without CGRP (n = 8).
(G) MDMs were stimulated by RANKL (75 ng/mL), CPBG (100 mg/mL), and CGRP (400 ng/mL). Jdp2 expression levels were quantified using qPCR (n = 3).
(H) MDMs were stimulated with RANKL and CGRP. After 3 days, osteoclast-associated gene expression levels were quantified by qPCR (n = 3).
(I) MDMs were stimulated with RANKL and CGRP. Culture supernatant concentrations of histone DNA were measured (n = 3).
(J) MDMs were stimulated with RANKL plus CGRP. cAMP levels in MDMs were quantified (n = 3).
(K) MDMs were stimulated with RANKL, CGRP, and cAMP (10 mM). After 5 hr, Jdp2 expression levels were quantified by qPCR (n = 3).
(L) MDMs were stimulated with RANKL for 3 days to generate osteoclasts. Cells were then treated with CGRP and cAMP for 3 or 12 hr. TRAP and phalloidin staining was performed to visualize osteoclasts and actin belt formation, respectively (n = 3). (M) DRG from WT mice were cultured in aMEM supplemented with 10% FCS. After 48 hr, culture supernatants were harvested (DRG culture sup). MDMs were cultured with RANKL, DRG culture supernatant, and olcegepant (CGRP receptor agonist). After 3 days, osteoclast numbers were counted (n = 6). Error bars represent SE; *p < 0.05; **p < 0.01; ***p < 0.001. diphtheria-toxin-based nociceptor ablation to explore the role of Nav1.8 positive nociceptors. Thus, Nav1.8-negative nociceptors may function to stimulate IL-17 and IL-23 expression in response to b-glucan. Further nociceptor-type-specific studies are needed to clarify the importance of pain neurons in fungal infections. Recently, it has been reported that Staphylococcus aureus skin infection directly activates nociceptors and that Nav1.8-positive nociceptors suppress hindpaw inflammation (Chiu et al., 2013) . Like S. aureus, C. albicans may directly stimulate nociceptors and evoke anti-inflammatory function. In this study, we also discovered that Dectin-1-mediated osteoinflammation, but not TLR4-mediated osteoinflammation, is potently suppressed by nociceptors. Strikingly, b-glucan-induced CGRP production from nociceptors was more potent than that induced by LPS. Thus, nociceptors may function mainly in fungal inflammation rather than in gram-negative bacterial inflammation.
Cross-talk between CGRP and Dectin-1 signaling in myeloid cells was responsible for the cAMP-mediated Jdp2 induction, causing suppression of inflammation. A significant discovery in this study is that Jdp2 physically binds to p65 and reduces p65 recruitment to the cytokine promoter. Jdp2 is a member of the AP-1 family of genes (c-Fos, Fra1, and Fra2), which are generally thought to be involved in suppression of TLR-mediated inflammation (Kim et al., 2005) . However, Jdp2 is likely to be suppressive toward p65 only after b-glucan plus CGRP stimulation, because mannan plus CGRP stimulation did not induce Jdp2. These findings are consistent with results showing that the Jdp2 deficiency hyper-inflammatory phenotype induced by CSBG was only observed in vivo.
In this study, we investigated how TRPV1/TRPA1 regulates the fungal osteoinflammation process. Nav1.8CreRosa26DTA mice showed impaired serum CGRP levels, causing reduced bone volume that results from increased osteoclastogenesis. By contrast, bone volume and CGRP levels in serum were normal in TRPV1-and/or TRPA1-deficient mice, suggesting that both ion channels are not involved in constitutive CGRP production. However, after CSBG injection into the hindpaw, serum CGRP induction was abolished in TRPV1/TRPA1 double-deficient mice, indicating that both ion channels are required for ''emergency'' CGRP induction. In vitro cytokine production or osteoclastogenesis in myeloid cells from TRPV1-and/or TRPA1-deficient mice were normal, and the levels of emergency CGRP induction in these mice may negatively correlate with in vivo inflammation. Further studies are required to reveal the mechanisms of TRP-channelmediated CGRP production in nociceptors.
In this study, we discovered that Nav1.8-positive nociceptors may function as protectors of fungal osteoinflammation via ''emergency'' CGRP production ( Figure 7I ). Thus, in the context of fungal infection, Nav1.8-positive nociceptors are ''regulatory neurons,'' and strategies to enhance CGRP secretion or Jdp2 activation might be beneficial to preventing the complications of b-glucan-associated inflammation or bone destruction. Despite these findings, the clinical implications of these denervated mouse phenotypes are still enigmatic. Congenital insensitivity to pain with anhidrosis is an extremely rare hereditary disease characterized by impairment of nociceptor development. Manifestations of congenital insensitivity to pain with anhidrosis are recurrent episodes of skin injury, osteomyelitis, bony fractures, and oral osteolysis (Butler et al., 2006; Swanson, 1963; Zhang and Haga, 2014) . Precise microbiological observation of this rare disease may clarify the bona fide role of human nociceptors in fungal infection. Dixit, respectively (Ruefli-Brasse et al., 2003; Xue et al., 2003) and were compared with WT littermate controls. Dectin1 À/À mice (Saijo et al., 2007) ,
Jdp2
À/À mice (Maruyama et al., 2012a) , and TLR4 À/À mice (Hoshino et al., 1999) were generated as described and were compared with WT littermate controls. TRPV1 À/À mice (Caterina et al., 2000) and TRPA1 À/À mice (original strain was backcrossed for more than eight generations with C57BL/6) (Bautista et al., 2006) were generated as described and control C57BL/6 mice were purchased from SLC. Rosa26-tdRFP reporter mice were generated as described previously (Luche et al., 2007 ) (Abrahamsen et al., 2008) . Animal experiments complied with the institutional animal care and use guidelines of Osaka 
Generation of Bone Marrow Chimeric Mice
Bone marrow transfer was performed as previously described (Maruyama et al., 2013) . Briefly, donor bone marrow cells from Jdp2 À/À and age-matched control wild-type mice were collected, and 1 3 10 7 cells were intravenously injected into lethally irradiated 4-week-old recipient mice. Mice were analyzed 7 weeks after bone marrow transplantation.
Denervation by RTX RTX (R8756, Sigma-Aldrich) was injected subcutaneously into the flank of 4-week-old female C57BL/6 mice at three escalating doses (80 ng/g body weight, 100 ng/g body weight, and 150 ng/g body weight) on consecutive days. Control mice were injected with DMSO containing PBS. Pain-nervedepleted 8-week-old female mice demonstrated cheek wiping <20 times per 5 min after injection of 50 mg capsaicin (M2028, Sigma-Aldrich) into the cheek.
Fungal Strain and b-Glucan C. albicans THK519, designated C. albicans, was obtained from a patient admitted to Tohoku University Hospital. CSBG and CPBG were prepared from C. albicans NRBC1385, which was purchased from the NITE Biological Resource Center, as previously described (Ishibashi et al., 2002) . Additional information on fungal and bacterial strains and on the cells and reagents used is provided in Supplemental Experimental Procedures.
In Vivo Injection of Pathogens and Their Components
Pathogen or ligand injection into the hindpaws of mice was performed as previously described (Chiu et al., 2013; Shimada and LaMotte, 2008) . Details on the pathogens and additional information on cell depletion and neutralizing antibodies can be found in Supplemental Experimental Procedures.
DRG Neuron Isolation
The DRGs were separated from L1 to L6 in mice. The DRG neurons were used for experiments between 2 and 6 hr after isolation. Details of the DRG neuron isolation technique are presented in Supplemental Experimental Procedures.
Histological and Radiological Analysis of Bone Tissue
To measure bone formation, double calcein labeling was performed. Tibias were fixed with 70% ethanol before being subjected to histological bone morphometric analysis. Three-dimensional micro-computed tomography (mCT) analysis of femurs and ankle joints was conducted using a Scan-Xmate RB080SS110 system (Comscan Techno). Bone structural indices were measured using TRI/3D-Bon software (Ratoc System Engineering). Additional information is provided in Supplemental Experimental Procedures.
PCR, Protein Analysis, Immunoprecipitation, and Viral Gene Transfer RNA was extracted using TRIzol (Invitrogen Life Science Technologies).
Reverse transcription was performed using ReverTra Ace (Toyobo). The quantity of mRNA was normalized to 18S rRNA using TaqMan ribosomal control reagent kit (Applied Biosystems). Western blotting was performed as previously described (Maruyama et al., 2012b) . For immunoprecipitation, pre-cleared cell lysates were incubated with protein A-Sepharose-containing antibodies for 1 hr. The immunoprecipitants were washed, eluted, and analyzed by western blotting. Chromatin immunoprecipitation was performed as previously described (Maruyama et al., 2013) . For viral gene transfer, retroviral packaging was performed using PlatE. Viral gene transduction to MDMs was performed as previously described (Maruyama et al., 2012a) . After transduction, MDMs were harvested and replated onto CSBG-or CPBG-containing tissue culture plates. In some experiments, cells were further stimulated with RANKL. Additional information is provided in Supplemental Experimental Procedures.
ELISA Kits used in this study included TNF-a and IL-6 ELISA kits (R&D Systems), CGRP ELISA kit (CSB-Equation 027706MO, Wuhan Humei Biotech), Galanin ELISA kit (CSB-EL009191MO, Wuhan Humei Biotech), Substance P EIA kit (583751, Cayman), Neurokinin A EIA kit (EIAM-NEA-1, RayBiotech), Somatostatin EIA kit (EIAM-SOM-1, RayBiotech), and TRACP5b ELISA kit (Immunodiagnostic Systems). Nuclear extracts were prepared as previously described (Maruyama et al., 2015) , and DNA-binding activity of NF-kB p65 was analyzed using an ELISA-based TransAM Transcription Factor Assay Kit (Active Motive).
Statistical Analysis
The difference in mean values between two groups was compared using the Student's t test, and p < 0.05 was considered to be significant. 
SUPPLEMENTAL INFORMATION
